Value proposition

A precision medicine company solving the critical issue of inadequate cancer treatments

Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improving patient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care.

Founded in 2024, Spotlight Medical is backed by Institut Curie and Gustave Roussy, and has raised more than 6 million Euros to implement its first AI-driven test in clinical routine set to be announced soon.